55 related articles for article (PubMed ID: 38053080)
1. Prognostic factors for intermediate- or high-risk neuroblastomas in children in China.
Zhang Y; Zhang WL; Huang DS; Wang YZ; Hu HM; Zhi T; Mei YY
BMC Pediatr; 2023 Dec; 23(1):617. PubMed ID: 38053080
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
5. Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries.
Karalexi MA; Servitzoglou M; Papadakis V; Kachanov D; Česen Mazič M; Baka M; Moschovi M; Kourti M; Polychronopoulou S; Stiakaki E; Hatzipantelis E; Dana H; Stefanaki K; Malama A; Themistocleous MS; Strantzia K; Shamanskaya T; Bouka P; Panagopoulou P; Kantzanou M; Ntzani E; Dessypris N; Petridou ET
Eur J Cancer Prev; 2023 May; 32(3):254-263. PubMed ID: 32925511
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
Kraal KC; van Dalen EC; Tytgat GA; Van Eck-Smit BL
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010349. PubMed ID: 28429876
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Workload of Pediatricians in China.
Zhang Y; Huang L; Zhou X; Zhang X; Ke Z; Wang Z; Chen Q; Dong X; Du L; Fang J; Feng X; Fu J; He Z; Huang G; Huang S; Ju X; Gao L; Li L; Li T; Li Y; Liu G; Liu W; Luo X; Nong G; Pan J; Shen K; Song H; Sun J; Mu D; Wang T; Wang B; Xiang W; Yang C; Yang S; Zhao Z; Zhu H; Zhu Y; Zhang J; Little J; Hesketh T; Sun K
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31253739
[TBL] [Abstract][Full Text] [Related]
8. Dinutuximab for maintenance therapy in pediatric neuroblastoma.
McGinty L; Kolesar J
Am J Health Syst Pharm; 2017 Apr; 74(8):563-567. PubMed ID: 28389455
[TBL] [Abstract][Full Text] [Related]
9. Overview and recent advances in the treatment of neuroblastoma.
Whittle SB; Smith V; Doherty E; Zhao S; McCarty S; Zage PE
Expert Rev Anticancer Ther; 2017 Apr; 17(4):369-386. PubMed ID: 28142287
[TBL] [Abstract][Full Text] [Related]
10. Research progress of neuroblastoma related gene variations.
Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.
Basta NO; Halliday GC; Makin G; Birch J; Feltbower R; Bown N; Elliott M; Moreno L; Barone G; Pearson AD; James PW; Tweddle DA; McNally RJ
Br J Cancer; 2016 Oct; 115(9):1048-1057. PubMed ID: 27701387
[TBL] [Abstract][Full Text] [Related]
12. Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text].
Bartholomew J; Washington T; Bergeron S; Nielson D; Saggio J; Quirk L
J Pediatr Oncol Nurs; 2017; 34(1):5-12. PubMed ID: 27456981
[TBL] [Abstract][Full Text] [Related]
13. Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma.
Mora J
Expert Rev Clin Pharmacol; 2016; 9(5):647-53. PubMed ID: 26934530
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
